Therapeutic potential of high-density lipoproteins in heart failure with reduced ejection fraction KU Leuven
Plasma high-density lipoprotein (HDL) cholesterol levels and plasma levels of its major apolipoprotein (apo), apo A-I, are inversely correlated with the incidence of coronary heart disease. The potential protection conferred by HDL against ischemic cardiovascular diseases has been most often attributed to its role in reverse cholesterol transport. However, HDLs exert divergent functions that include actions mediated by signalling via ...